Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management
NCT03001453
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Pain, Postoperative
Interventions
DRUG:
Liposomal Bupivacaine
DRUG:
0.25% Bupivacaine with epinephrine
DRUG:
Saline
Sponsor
American Hip Institute